LABA

adrenoceptor beta 2 ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33622325 Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells. 2021 Feb 23 1
2 34128573 ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis. 2021 Sep 2
3 30872116 Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. 2019 Aug 1
4 28987803 Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation. 2018 Feb 1
5 29115880 Treatment response heterogeneity in asthma: the role of genetic variation. 2018 Jan 1
6 29650006 Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. 2018 Apr 12 1
7 29653961 Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists. 2018 Jul 1
8 29992699 Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review. 2018 Nov 1
9 30311516 Olodaterol for the treatment of chronic obstructive pulmonary disease: a narrative review. 2018 Oct 1
10 27050801 Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma. 2016 Oct 2
11 27452453 Triple inhaled therapy for chronic obstructive pulmonary disease. 2016 Nov 1
12 27582089 Vilanterol and fluticasone furoate for asthma. 2016 Sep 1 1
13 25377687 New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives. 2015 May 1
14 26676161 Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterol. 2015 1
15 24621682 Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. 2014 Mar 3
16 24641588 Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management. 2014 Jul 1
17 24279851 Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort. 2013 Dec 2
18 22526864 β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients. 2012 Aug 2
19 19430548 Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment. 2009 Apr 30 2
20 17901197 Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. 2008 Jan 1
21 18023995 Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease. 2008 Feb 1
22 18071293 A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. 2008 Mar 1
23 18666664 [Practice guideline 'Medical treatment of COPD']. 2008 Jun 28 1
24 16872239 Long-acting beta2-agonists in asthma: not so SMART? 2006 1
25 14668964 Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype. 2004 Jan 1
26 14524296 [How to obtain complete control of asthma?]. 2003 Jun 2
27 14651722 Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. 2003 Nov 1